He did exhaustive research. He found there’d been decades of scientific studies on the effects of THC and CBD on cells and animals, but few trials with humans, because the FDA classifies cannabis and all its components as Schedule 1 drugs, which have “no accepted medical treatment use.” It took Sue Sisley, an Arizona physician, seven years of struggling with bureaucratic hurdles before she received the first FDA approval for a study, just beginning, of marijuana with vets who have PTSD.
With all of the information inundating the internet about CBD oil, many people are curious, can CBD help with weight loss? A study done in 2012 documented the way that cannabinol and cannabidiol affected the feeding patterns in rats. After dosing rats with CBD, the scientists observed that they ate less; this set the stage for more research to be done to continue to show the weight loss opportunities with CBD. It also brought into light a new use for CBD as an appetite suppressant. In addition to that, a report in India Times in 2016 said that cannabis users show a lower rate of obesity and diabetes. Science has also demonstrated links between the use of cannabis and metabolism for many years.
Scientists have only scraped the tip of the iceberg so far. The DEA has recently removed CBD from its list of controlled substances. This significant event paves the way for government-funded grants that will allow some of the best minds in the world study cannabidiol’s effect on the human body. It will be exciting to see what is uncovered in the years to come. For the time being, evidence points to CBD’s use as a valuable tool for losing weight. And because it is safe and readily available in most places (check your own state to be sure), it is a simple way of supplementing your health as you attempt to shed unwanted pounds.
Interestingly, over-activation of the endocannabinoid system, primarily via CB1 receptor activation, contributes to increased abdominal obesity (i.e., fat gain along the midsection), glucose uptake into adipocytes (fat cells), and insulin resistance in muscle tissue. This “metabolic dysfunction” sets up a vicious cycle whereby further insulin resistance in muscles and the liver increases abdominal obesity and further CB1 over-activation, resulting in greater food-seeking behavior, increased appetite, and increased body fat gain.
To briefly review, the endocannabinoid system (ECS) is a group of specialized fatty acid-based signaling chemicals (think “keys”), their receptors (think “locks”), and the metabolic enzymes that produce and break them down. These endocannabinoid chemical signals act on similar brain and immune cell receptors (CB1 and CB2) using the active compounds found in cannabis – cannabidiol (CBD), and Δ9-tetrahydrocannabinol (THC).
Dietary changes are the most important action individuals can choose to get off the roller coaster. But CBD could lend a hand in the process. A 2018 study showed that the cannabinoids THC, CBD and CBN enhance cells’ ability to take up glucose. And they perform even better than metformin, a common pharmaceutical prescribed to lower elevated blood glucose.
Cannabidiol (CBD) is one of over 100 phytocannabinoids found in marijuana and hemp plants. Together with tetrahydrocannabinol (THC), CBD is a cannabinoid intensely investigated for its health properties. Unlike THC, CBD is not psychoactive. This means that when CBD is consumed, it produces no psychological effects, or the controversial “high” marijuana is well known for.